Predict your next investment

Biolog company logo
HEALTHCARE | Biotechnology
biolog.com

See what CB Insights has to offer

About Biolog

Biolog, Inc. is a company that began operations in 1984. The company's product lines have been built upon patented technology that greatly aims to simplify testing of cells. Biolog's first products were introduced in 1988 and by 1990 it had established a profitable growing business in microbiology for the identification and characterization of microbial cells. In 1991, Biolog, Inc. was a recipient of the "R&D 100 Award" for the company's groundbreaking bacterial identification products. These products, marketed under the MicroLog, MicroStation and OmniLog brand names, are sold worldwide through direct sales as well as distribution. The principal customers of the company's microbiology identification products are laboratories needing capabilities, especially pharmaceutical, biotech, cosmetics, and medical device companies, university and government research laboratories, labs testing for diseases in animals and plants, labs performing environmental monitoring, and companies or organizations involved in production or testing of food and drink. From this technology base in 1999 and with an SBIR award from the National Institutes for Health Human Genome Research Institute, Biolog began development of its Phenotype MicroArray technology. This technology aims to allow researchers to evaluate thousands of cellular phenotypes simultaneously in both microbial and mammalian cells. Development of array sets testing 2,000 phenotypes of microbial cells was completed and first introduced in September 2001. Now Phenotype MicroArray technology is being tested under license in many pharmaceutical and biotechnology companies for use in drug and enzyme development programs. Biolog continues to develop and patent technologies that allow scientists to broadly characterize cellular functions using arrays of phenotypic tests. In addition to revenue from product sales, Biolog has received funding from private investments and Small Business Innovation Research (SBIR) grants and contracts from the National Institutes for Health (NIH), Department of Energy (DOE), National Aeronautics and Space Administration (NASA) and the National Science Foundation (NSF).

Biolog Headquarter Location

21124 Cabot Blvd.

Hayward, California, 94545,

United States

Latest Biolog News

Biolog-id and Fujicom Join Their Forces to Distribute Biolog Transfusion Solution on the Brazilian Market

Sep 28, 2021

Biolog-id and Fujicom Join Their Forces to Distribute Biolog Transfusion Solution on the Brazilian Market Biolog-id develops and implements innovative solutions, that digitally transform routine processes into actionable data Biolog-id and Fujicom Join Their Forces. Biolog-id, a global service provider of connected healthcare solutions, and Fujicom, a national distributor of high-quality medical-hospital products and services, get into a partnership to offer Biolog Transfusion Solution on the Brazilian market. With more than 40 years of experience in the healthcare sector, Fujicom is a leading supplier in the market by providing high technology medical equipment. Throughout Brazil, the company provides more than 500 customers such as blood centers, public and private blood banks, hospitals and clinics with breakthrough and innovative products. Flexible and reliable, Biolog Transfusion Solution combines software, equipment and RFID tags offering a comprehensive solution for blood components traceability, from the collection to the hospital blood banks. Divided into several modules (Processing, Inventory and Transport) addressing each application area of the transfusion supply chain, this solution optimizes the management of the lifesaving medical resources while enhancing operational efficiency. “Due to its core business and its well-recognized experience, Fujicom is without a doubt a key player on the Brazilian transfusion market. We are very pleased to cooperate with them.” explains Philippe Jacquet, Executive Director of Sales EMEA/LATAM at biolog-id. “Several opportunities have already been identified and we are confident that during the coming months, Fujicom will manage those toward a positive conclusion and implementation”. “The arrival of biolog-id’s innovative solution on the Brazilian blood bank market will foster the improvement of the traceability and control of processes that remain non-automated yet” underlines Sandra Fujita, Commercial Director at Fujicom. “Based on RFID technology, it will ensure our clients a more efficient management of their product inventory by improving the profitability and the quality of the services provided.” As previously announced, biolog-id and Fujicom will rely on the expertise of SBS Consultores system – a leading Brazilian software company well established in the transfusion sector – to integrate and implement Biolog Transfusion Solution while providing on-site support. Source: Company Press Release

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Biolog Patents

Biolog has filed 6 patents.

The 3 most popular patent topics include:

  • Accentor-class minesweepers
  • Blood tests
  • Drug control law
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/24/2016

2/16/2021

Drug control law, Red blood cell disorders, Accentor-class minesweepers, Blood tests, Transfusion medicine

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/24/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

2/16/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Drug control law, Red blood cell disorders, Accentor-class minesweepers, Blood tests, Transfusion medicine

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Biolog Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Biolog Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.